Please use this identifier to cite or link to this item:
Title: Natural killer cell recognition of melanoma: new clues for a more effective immunotherapy
Authors: Tarazona Lafarga, Raquel
Durán Flórez, Esther
Solana Lara, Rafael
Keywords: Melanoma;Inmunoterapia;Células asesinas;Control del bloqueo inmunológico;Transferencia de células adoptivas;Immunotherapy;Natural killer cells;Adoptive transfer;Checkpoint blockade
Issue Date: 2016
Publisher: Frontiers Media
Abstract: Natural killer (NK) cells participate in the early immune response against melanoma and also contribute to the development of an adequate adaptive immune response by their crosstalk with dendritic cells and cytokine secretion. Melanoma resistance to conventional therapies together with its high immunogenicity justifies the development of novel therapies aimed to stimulate effective immune responses against melanoma. However, melanoma cells frequently escape to CD8 T cell recognition by the down-regulation of major histocompatibility complex (MHC) class I molecules. In this scenario, NK cells emerge as potential candidates for melanoma immunotherapy due to their capacity to recognize and destroy melanoma cells expressing low levels of MHC class I molecules. In addition, the possibility to combine immune checkpoint blockade with other NK cell potentiating strategies (e.g., cytokine induction of activating receptors) has opened new perspectives in the potential use of adoptive NK cell-based immunotherapy in melanoma.
ISSN: 1664-3224
DOI: 10.3389/fimmu.2015.00649
Appears in Collections:DFSIO - Artículos
DMANI - Artículos

Files in This Item:
File Description SizeFormat 
fimmu_2015_00649.pdf343,52 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons